Balance Sheet
Cash Flow Statement
Daily Values
DMA 100DMA 200DMA 50Dividend YieldEV to CFOEV to EBITEV to EBITDAEV to FCFEV to RevenueEnterprise ValueMarket Cap to FCFMarket CapitalizationPricePrice to EarningsPrice to Sales
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Cryo Cell International (CCEL) Enterprise Value (2016 - 2026)

Cryo Cell International's Enterprise Value history spans 17 years, with the latest figure at -$2.9 million for Q1 2026.

  • Quarterly results put Enterprise Value at -$2.9 million for Q1 2026, up 16.65% from a year ago — trailing twelve months through Feb 2026 was -$2.9 million (up 16.65% YoY), and the annual figure for FY2025 was -$3.3 million, up 5.72%.
  • Enterprise Value for Q1 2026 was -$2.9 million at Cryo Cell International, up from -$3.3 million in the prior quarter.
  • In the past five years, Enterprise Value ranged from a high of -$979593.0 in Q1 2024 to a low of -$4.4 million in Q2 2025.
  • The 5-year median for Enterprise Value is -$2.6 million (2022), against an average of -$2.5 million.
  • The sharpest move saw Enterprise Value surged 79.35% in 2022, then plummeted 256.66% in 2024.
  • Year by year, Enterprise Value stood at -$1.7 million in 2022, then skyrocketed by 43.06% to -$980250.0 in 2023, then plummeted by 256.66% to -$3.5 million in 2024, then grew by 5.72% to -$3.3 million in 2025, then rose by 12.01% to -$2.9 million in 2026.
  • According to Business Quant data, Enterprise Value over the past three periods came in at -$2.9 million, -$3.3 million, and -$3.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.